Congratulations to Richard Macaulay on his well-attended presentation “The New SMC-Ultra-Orphan Pathway: HTA Best Practice for Very Rare Diseases?” Did you miss PRECISIONadvisors at Virtual ISPOR 2021? Check out all of our posters presented at the conference here:

Day 1:

• Latin America HTA: Brazil and Argentina Report Card
• Canadian Pricing and Reimbursement: Understanding the Biggest Hurdles in the Payer Landscape
• The “NICEness” of NICE: A Time-Trend Analysis
• Impact of COVID on Health Technology Assessment bodies
• The Second Coming of the Nice Appeal Process?

Day 2:

• Innovative Approaches to Cancer Therapy Provision in the COVID-Era
• Is the Cancer Drugs Fund Functioning As Anticipated?

Day 3:

• Global Access Implications of Germany’s New GSAV LAW for Orphan Drugs

For more information about the PRECISIONadvisors presentation and posters, click here!